R. Siegel, D. Naishadham, and A. Jemal, Cancer statistics, 2013, CA: A Cancer Journal for Clinicians, vol.287, issue.suppl 5, pp.11-30, 2013.
DOI : 10.3322/caac.21166

D. Mcleod, Tolerability of Nonsteroidal Antiandrogens in the Treatment of Advanced Prostate Cancer, Oncologist, vol.2, pp.18-27, 1997.

D. Wysowski, J. Freiman, J. Tourtelot, and M. Horton, Fatal and Nonfatal Hepatotoxicity Associated with Flutamide, Annals of Internal Medicine, vol.118, issue.11, pp.860-864, 1993.
DOI : 10.7326/0003-4819-118-11-199306010-00006

L. Bjeldanes, J. Kim, K. Grose, J. Bartholomew, and C. Bradfield, Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin., Proceedings of the National Academy of Sciences, vol.88, issue.21, pp.9543-9547, 1991.
DOI : 10.1073/pnas.88.21.9543

D. Kruif, C. Marsman, J. Venekamp, J. Falke, H. Noordhoek et al., Structure elucidation of acid reaction products of indole-3-carbinol: Detection in vivo and enzyme induction in vitro, Chemico-Biological Interactions, vol.80, issue.3, pp.303-315, 1991.
DOI : 10.1016/0009-2797(91)90090-T

M. Nachshon-kedmi, F. Fares, and S. Yannai, Therapeutic activity of 3,3?-diindolylmethane on prostate cancer in an in vivo model, The Prostate, vol.19, issue.2, pp.153-160, 2004.
DOI : 10.1002/pros.20092

E. Heath, L. Heilbrun, J. Li, U. Vaishampayan, F. Harper et al., A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3'-Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer, Am J Transl Res, vol.2, pp.402-411, 2010.

M. Bhuiyan, Y. Li, S. Banerjee, F. Ahmed, Z. Wang et al., Down-regulation of Androgen Receptor by 3,3'-Diindolylmethane Contributes to Inhibition of Cell Proliferation and Induction of Apoptosis in Both Hormone-Sensitive LNCaP and Insensitive C4-2B Prostate Cancer Cells, Cancer Research, vol.66, issue.20, pp.10064-10072, 2006.
DOI : 10.1158/0008-5472.CAN-06-2011

H. Le, C. Schaldach, G. Firestone, and L. Bjeldanes, Plant-derived 3,3???-Diindolylmethane Is a Strong Androgen Antagonist in Human Prostate Cancer Cells, Journal of Biological Chemistry, vol.278, issue.23, pp.21136-21145, 2003.
DOI : 10.1074/jbc.M300588200

K. Abdelbaqi, N. Lack, E. Guns, L. Kotha, S. Safe et al., Antiandrogenic and growth inhibitory effects of ring-substituted analogs of 3,3???-diindolylmethane (Ring-DIMs) in hormone-responsive LNCaP human prostate cancer cells, The Prostate, vol.27, issue.6, pp.1401-1412, 2011.
DOI : 10.1002/pros.21356
URL : https://hal.archives-ouvertes.fr/pasteur-00722978

T. Wang, N. Schoene, J. Milner, and Y. Kim, Broccoli-derived phytochemicals indole-3-carbinol and 3,3???-diindolylmethane exerts concentration-dependent pleiotropic effects on prostate cancer cells: Comparison with other cancer preventive phytochemicals, Molecular Carcinogenesis, vol.26, issue.182, pp.244-256, 2012.
DOI : 10.1002/mc.20774

K. Chinnakannu, D. Chen, Y. Li, Z. Wang, Q. Dou et al., Cell Cycle-Dependent Effects of 3,3???-Diindolylmethane on Proliferation and Apoptosis of Prostate Cancer Cells, Journal of Cellular Physiology, vol.98, issue.1, pp.94-99, 2009.
DOI : 10.1002/jcp.21650

N. Gao, S. Cheng, A. Budhraja, E. Liu, J. Chen et al., 3, 3???-Diindolylmethane Exhibits Antileukemic Activity In Vitro and In Vivo through a Akt-Dependent Process, PLoS ONE, vol.1, issue.29, p.31783, 2012.
DOI : 10.1371/journal.pone.0031783.g006

V. Garikapaty, B. Ashok, K. Tadi, A. Mittelman, and R. Tiwari, 3,3???-Diindolylmethane downregulates pro-survival pathway in hormone independent prostate cancer, Biochemical and Biophysical Research Communications, vol.340, issue.2, pp.718-725, 2006.
DOI : 10.1016/j.bbrc.2005.12.059

D. Kong, S. Banerjee, W. Huang, Y. Li, Z. Wang et al., Mammalian Target of Rapamycin Repression by 3,3'-Diindolylmethane Inhibits Invasion and Angiogenesis in Platelet-Derived Growth Factor-D-Overexpressing PC3 Cells, Cancer Research, vol.68, issue.6, pp.1927-1934, 2008.
DOI : 10.1158/0008-5472.CAN-07-3241

A. Goldberg, V. Titorenko, A. Beach, K. Abdelbaqi, S. Safe et al., Ring-substituted analogs of 3,3???-diindolylmethane (DIM) induce apoptosis and necrosis in androgen-dependent and ???independent prostate cancer cells, Investigational New Drugs, vol.557, issue.Pt 1, 2013.
DOI : 10.1007/s10637-013-9979-y
URL : https://hal.archives-ouvertes.fr/pasteur-01135724

Y. Li, Z. Wang, D. Kong, S. Murthy, Q. Dou et al., Regulation of FOXO3a/beta-Catenin/GSK-3beta Signaling by 3,3'-Diindolylmethane Contributes to Inhibition of Cell Proliferation and Induction of Apoptosis in Prostate Cancer Cells, Journal of Biological Chemistry, vol.282, issue.29, pp.21542-21550, 2007.
DOI : 10.1074/jbc.M701978200

X. Li, E. Park, M. Park, and S. Kim, 3,3'-Diindolylmethane suppresses the growth of gastric cancer cells via activation of the Hippo signaling pathway, Oncol Rep, vol.30, pp.2419-2426, 2013.

M. Nachshon-kedmi, S. Yannai, A. Haj, and F. Fares, Indole-3-carbinol and 3,3???-diindolylmethane induce apoptosis in human prostate cancer cells, Food and Chemical Toxicology, vol.41, issue.6, pp.745-752, 2003.
DOI : 10.1016/S0278-6915(03)00004-8

M. Abdelrahim, K. Newman, K. Vanderlaag, I. Samudio, and S. Safe, 3,3'-Diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5, Carcinogenesis, vol.27, issue.4, pp.717-728, 2006.
DOI : 10.1093/carcin/bgi270

J. Savino, J. Evans, D. Rabinowitz, K. Auborn, and T. Carter, Multiple, disparate roles for calcium signaling in apoptosis of human prostate and cervical cancer cells exposed to diindolylmethane, Molecular Cancer Therapeutics, vol.5, issue.3, pp.556-563, 2006.
DOI : 10.1158/1535-7163.MCT-05-0355

S. Sun, J. Han, W. Ralph, J. Chandrasekaran, A. Liu et al., Endoplasmic reticulum stress as a correlate of cytotoxicity in human tumor cells exposed to diindolylmethane in vitro, Cell Stress & Chaperones, vol.12, issue.1, pp.76-87, 2004.
DOI : 10.1379/1466-1268(2004)009<0076:ERSAAC>2.0.CO;2

Y. Gong, H. Sohn, L. Xue, G. Firestone, and L. Bjeldanes, 3,3'-Diindolylmethane Is a Novel Mitochondrial H+-ATP Synthase Inhibitor that Can Induce p21Cip1/Waf1 Expression by Induction of Oxidative Stress in Human Breast Cancer Cells, Cancer Research, vol.66, issue.9, pp.4880-4887, 2006.
DOI : 10.1158/0008-5472.CAN-05-4162

J. Riby, G. Firestone, and L. Bjeldanes, 3,3???-Diindolylmethane reduces levels of HIF-1?? and HIF-1 activity in hypoxic cultured human cancer cells, Biochemical Pharmacology, vol.75, issue.9, pp.1858-1867, 2008.
DOI : 10.1016/j.bcp.2008.01.017

A. Roy, A. Ganguly, S. Bosedasgupta, B. Das, C. Pal et al., Mitochondria-Dependent Reactive Oxygen Species-Mediated Programmed Cell Death Induced by 3,3'-Diindolylmethane through Inhibition of F0F1-ATP Synthase in Unicellular Protozoan Parasite Leishmania donovani, Molecular Pharmacology, vol.74, issue.5, pp.1292-1307, 2008.
DOI : 10.1124/mol.108.050161

P. Kandala and S. Srivastava, Regulation of macroautophagy in ovarian cancer cells in vitro and in vivo by controlling Glucose regulatory protein 78 and AMPK, Oncotarget, vol.3, issue.4, pp.435-449, 2012.
DOI : 10.18632/oncotarget.483

L. Genes&cancer, E. Houseman, D. Williams, R. Dashwood, and E. Ho, Effects of sulforaphane and 3,3'-diindolylmethane on genome-wide promoter methylation in normal prostate epithelial cells and prostate cancer cells, PLoS One, vol.9, p.86787, 2014.

C. Schneider, W. Rasband, and K. Eliceiri, NIH Image to ImageJ: 25 years of image analysis, Nature Methods, vol.42, issue.7, pp.671-675, 2012.
DOI : 10.1038/nmeth.2089

R. Guha, M. Howard, G. Hutchison, P. Murray-rust, H. Rzepa et al., The Blue Obelisk???Interoperability in Chemical Informatics, Journal of Chemical Information and Modeling, vol.46, issue.3, pp.991-998, 2006.
DOI : 10.1021/ci050400b

G. Morris, R. Huey, W. Lindstrom, M. Sanner, R. Belew et al., AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility, Journal of Computational Chemistry, vol.22, issue.16, pp.2785-2791, 2009.
DOI : 10.1002/jcc.21256

H. Berman, J. Westbrook, Z. Feng, G. Gilliland, T. Bhat et al., The Protein Data Bank, Nucleic Acids Research, vol.28, issue.1, pp.235-242, 2000.
DOI : 10.1093/nar/28.1.235

C. Hetenyi and D. Van-der-spoel, Efficient docking of peptides to proteins without prior knowledge of the binding site, Protein Science, vol.307, issue.7, pp.1729-1737, 2002.
DOI : 10.1110/ps.0202302

S. Lim, M. Rahman, and B. Tejo, Structure-based and ligand-based virtual screening of novel methyltransferase inhibitors of the dengue virus, BMC Bioinformatics, vol.12, issue.Suppl 13, p.24, 2011.
DOI : 10.1093/protein/8.2.127

O. Trott and A. Olson, AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, Journal of Computational Chemistry, vol.17, pp.455-461, 2010.
DOI : 10.1002/jcc.21334

N. Ranjan, K. Andreasen, S. Kumar, D. Hyde-volpe, and D. Arya, Telomeric DNA, Biochemistry, vol.49, issue.45, pp.9891-9903, 2010.
DOI : 10.1021/bi101517e

G. Wolber and T. Langer, LigandScout:?? 3-D Pharmacophores Derived from Protein-Bound Ligands and Their Use as Virtual Screening Filters, Journal of Chemical Information and Modeling, vol.45, issue.1, pp.160-169, 2005.
DOI : 10.1021/ci049885e

S. Durdagi, H. Duff, and S. Noskov, Combined Receptor and Ligand-Based Approach to the Universal Pharmacophore Model Development for Studies of Drug Blockade to the hERG1 Pore Domain, Journal of Chemical Information and Modeling, vol.51, issue.2, pp.463-474, 2011.
DOI : 10.1021/ci100409y

Z. Mounir, J. Krishnamoorthy, S. Wang, B. Papadopoulou, S. Campbell et al., Akt determines cell fate through inhibition of the PERK- eIF2alpha phosphorylation pathway, Sci Signal, vol.4, p.62, 2011.

K. Rahman and F. Sarkar, Inhibition of nuclear translocation of nuclear factor-{kappa}B contributes to 3,3'-diindolylmethane-induced apoptosis in breast cancer cells, Cancer Res, vol.65, pp.364-371, 2005.

X. Huang, Y. Chen, H. Zhang, Q. Ma, Y. Zhang et al., Salubrinal attenuates beta-amyloid-induced neuronal death and microglial activation by inhibition of the NF-kappaB pathway, Neurobiol Aging, vol.33, pp.1007-1009, 2012.

D. Kessel, Protection of Bcl-2 by salubrinal, Biochemical and Biophysical Research Communications, vol.346, issue.4, pp.1320-1323, 2006.
DOI : 10.1016/j.bbrc.2006.06.056

D. Ouyang, L. Xu, X. He, Y. Zhang, L. Zeng et al., Autophagy is differentially induced in prostate cancer LNCaP, DU145 and PC-3 cells via distinct splicing profiles of ATG5, Autophagy, vol.39, issue.1, pp.20-32, 2013.
DOI : 10.1093/abbs/gmq019

O. Rokhlin, A. Taghiyev, K. Bayer, D. Bumcrot, V. Koteliansk et al., Calcium/calmodulin-dependent kinase II plays an important role in prostate cancer cell survival, Cancer Biology & Therapy, vol.6, issue.5, pp.732-742, 2007.
DOI : 10.4161/cbt.6.5.3975

Y. Liu and D. Templeton, : Involvement of p38 kinase and CaMK-II, Journal of Cellular Physiology, vol.164, issue.2, pp.307-318, 2008.
DOI : 10.1002/jcp.21499

J. Timmins, L. Ozcan, T. Seimon, G. Li, C. Malagelada et al., Calcium/calmodulin-dependent protein kinase II links ER stress with Fas and mitochondrial apoptosis pathways, Journal of Clinical Investigation, vol.119, issue.10, pp.2925-2941, 2009.
DOI : 10.1172/JCI38857

O. Mamaeva, J. Kim, G. Feng, and J. Mcdonald, Calcium/calmodulin-dependent kinase II regulates notch-1 signaling in prostate cancer cells, Journal of Cellular Biochemistry, vol.280, issue.8, pp.25-32, 2009.
DOI : 10.1002/jcb.21973